Source Class, Target Class, Score
Geographic Region,pathogen death temporal region,0.7053191489361703
Geographic Region,infection incidence proportion profile,0.6136363636363636
Geographic Region,zero-dimensional temporal region,0.6744897959183673
Geographic Region,incubation end process boundary,0.5958333333333333
Geographic Region,communicability start temporal region,0.6537037037037037
Geographic Region,infectious disease course,0.5928571428571429
Geographic Region,one-dimensional spatial region,0.7053191489361703
Geographic Region,zero-dimensional spatial region,0.7
Geographic Region,spatiotemporal region,0.7394736842105263
Geographic Region,latency end temporal region,0.7
Geographic Region,communicability end process boundary,0.6009433962264151
Geographic Region,temporal region,0.79375
Geographic Region,two-dimensional spatial region,0.7053191489361703
Geographic Region,long-term non-progressing infectious disease course,0.5970588235294118
Geographic Region,acute infectious disease course,0.575
Geographic Region,infection incidence proportion,0.6414893617021277
Geographic Region,spatial region,0.7403225806451613
Geographic Region,infection start temporal region,0.6791666666666666
Geographic Region,one-dimensional temporal region,0.6791666666666666
Geographic Region,country,0.575
Geographic Region,local infection,0.66875
Geographic Region,division of geopolitical entity,0.6375
Geographic Region,place closure control strategy,0.6202127659574468
Geographic Region,establishment of a clinically abnormal colony,0.5951612903225807
Geographic Region,incubation end temporal region,0.6840425531914894
Geographic Region,geographical region,0.9222222222222223
Geographic Region,latency end process boundary,0.6055555555555556
Geographic Region,object,0.5369565217391304
Geographic Region,T cell receptor complex,0.575
Geographic Region,B cell receptor complex,0.575
Geographic Region,disease course,0.6112903225806451
Geographic Region,chronic infectious disease course,0.59
Geographic Region,infection end temporal region,0.6891304347826087
Geographic Region,objective specification,0.625
Geographic Region,infectious disease incidence proportion,0.6285714285714286
Geographic Region,three-dimensional spatial region,0.6948979591836735
Geographic Region,communicability end temporal region,0.6615384615384616
Geographic Region,pathogen birth temporal region,0.7053191489361703
Geographic Region,geospatial region,0.8029411764705883
Geographic Region,disease surveillance objective specification,0.5975409836065574
Geographic Region,infectious disease control objective specification,0.5843283582089552
Geographic Region,object aggregate,0.6318181818181818
Coronavirus infection,infection incidence proportion profile,0.6533898305084747
Coronavirus infection,infectious disposition,0.6825581395348838
Coronavirus infection,fungicidal disposition,0.6593023255813953
Coronavirus infection,collective pathogenic disposition,0.6537037037037037
Coronavirus infection,primary infection role,0.7523255813953489
Coronavirus infection,systematic infection,0.7426829268292683
Coronavirus infection,immunosuppressive disposition,0.65
Coronavirus infection,incubation end process boundary,0.6038461538461539
Coronavirus infection,communicability start temporal region,0.6396551724137931
Coronavirus infection,infectious disease course,0.6456521739130434
Coronavirus infection,disease transmission model,0.598936170212766
Coronavirus infection,secondary infection role,0.7833333333333333
Coronavirus infection,collective resistance disposition,0.6722222222222223
Coronavirus infection,adhesion disposition,0.6695121951219513
Coronavirus infection,bactericidal disposition,0.6722222222222223
Coronavirus infection,static agent disposition,0.65
Coronavirus infection,source of infection role,0.7388888888888888
Coronavirus infection,communicability,0.6444444444444444
Coronavirus infection,community-acquired infection,0.7765306122448979
Coronavirus infection,toxin disposition,0.6868421052631578
Coronavirus infection,secondary infection,0.825
Coronavirus infection,source of infection site,0.7388888888888888
Coronavirus infection,primary infectious disposition,0.7049019607843137
Coronavirus infection,infection,0.75
Coronavirus infection,infection incidence rate profile,0.6386792452830189
Coronavirus infection,bacteriostatic disposition,0.6840425531914894
Coronavirus infection,latency end temporal region,0.6375
Coronavirus infection,communicability end process boundary,0.6254385964912281
Coronavirus infection,infectious disease lifetime prevalence,0.6364406779661017
Coronavirus infection,infectious disease mortality rate,0.6166666666666667
Coronavirus infection,infectious disorder,0.65
Coronavirus infection,disposition,0.66875
Coronavirus infection,infectious disease control strategy,0.6285714285714286
Coronavirus infection,infection incidence,0.675
Coronavirus infection,infectious disease epidemic,0.6166666666666667
Coronavirus infection,appearance of disorder,0.5895348837209302
Coronavirus infection,invasive disposition,0.6939024390243902
Coronavirus infection,infection incidence profile,0.6375
Coronavirus infection,source of infection,0.775
Coronavirus infection,long-term non-progressing infectious disease course,0.6583333333333334
Coronavirus infection,parasitostatic disposition,0.6627659574468084
Coronavirus infection,infectious disease sporadicity,0.6264705882352941
Coronavirus infection,infectious disease pandemic,0.6375
Coronavirus infection,communicability start process boundary,0.6194915254237288
Coronavirus infection,acute infectious disease course,0.6615384615384616
Coronavirus infection,infection incidence proportion,0.6852941176470588
Coronavirus infection,infection start temporal region,0.6423076923076922
Coronavirus infection,local infection,0.7833333333333333
Coronavirus infection,pathogenic disposition,0.6593023255813953
Coronavirus infection,action specification,0.7182926829268292
Coronavirus infection,primary infection,0.7921052631578948
Coronavirus infection,infectious disease endemicity,0.65
Coronavirus infection,disease,0.5571428571428572
Coronavirus infection,establishment of a clinically abnormal colony,0.5863636363636363
Coronavirus infection,transmissibility disposition,0.6540816326530612
Coronavirus infection,extracellular infection,0.7454545454545455
Coronavirus infection,infection start process boundary,0.619811320754717
Coronavirus infection,virulence factor disposition,0.6744897959183673
Coronavirus infection,communicability interval,0.65
Coronavirus infection,incubation end temporal region,0.6264705882352941
Coronavirus infection,hospital-acquired infection,0.7416666666666667
Coronavirus infection,disorder,0.553448275862069
Coronavirus infection,contagiousness,0.7071428571428571
Coronavirus infection,exotoxin disposition,0.6939024390243902
Coronavirus infection,infectious disease,0.6551282051282051
Coronavirus infection,opportunistic infectious disposition,0.7131578947368421
Coronavirus infection,fungistatic disposition,0.6545454545454545
Coronavirus infection,chronic infection,0.8447368421052631
Coronavirus infection,metastatic infection,0.7426829268292683
Coronavirus infection,latency end process boundary,0.5928571428571429
Coronavirus infection,process of establishing an infection,0.7131578947368421
Coronavirus infection,cytotoxin disposition,0.7119047619047619
Coronavirus infection,T cell receptor complex,0.609090909090909
Coronavirus infection,intracellular infection,0.7454545454545455
Coronavirus infection,cidal agent disposition,0.6545454545454545
Coronavirus infection,subclinical infection,0.7595238095238095
Coronavirus infection,zoonotic disposition,0.6939024390243902
Coronavirus infection,B cell receptor complex,0.609090909090909
Coronavirus infection,site of infection,0.7394736842105263
Coronavirus infection,endotoxin disposition,0.6880952380952381
Coronavirus infection,disease course,0.5928571428571429
Coronavirus infection,infectious disease prevalence,0.63
Coronavirus infection,chronic infectious disease course,0.7092592592592593
Coronavirus infection,invasion disposition,0.6695121951219513
Coronavirus infection,infection prevalence,0.6695121951219513
Coronavirus infection,infection incidence rate,0.65
Coronavirus infection,infection end temporal region,0.63
Coronavirus infection,enterotoxin disposition,0.6772727272727272
Coronavirus infection,parasiticidal disposition,0.6456521739130434
Coronavirus infection,simple infection,0.7472972972972972
Coronavirus infection,complex infection,0.7657894736842106
Coronavirus infection,infectious disease incidence proportion,0.6666666666666667
Coronavirus infection,infectious disease incidence rate,0.6351851851851852
Coronavirus infection,communicability end temporal region,0.6464285714285714
Coronavirus infection,neurotoxin disposition,0.6825581395348838
Coronavirus infection,infectious disease incidence,0.6540816326530612
Coronavirus infection,disease surveillance objective specification,0.6192307692307693
Coronavirus infection,infectious disease control objective specification,0.6330985915492958
Coronavirus infection,nursing-home acquired infection,0.7384615384615384
Coronavirus infection,reverse zoonotic disposition,0.6744897959183673
Coronavirus infection,acute infection,0.7833333333333333
Coronavirus infection,collective disposition,0.6825581395348838
Gender type,case isolation control strategy,0.5928571428571429
Gender type,incubation end process boundary,0.5928571428571429
Gender type,macromolecular complex,0.6015151515151516
Gender type,infection incidence rate profile,0.636046511627907
Gender type,latency end temporal region,0.6342105263157894
Gender type,communicability end process boundary,0.5776595744680851
Gender type,infectious disease mortality rate,0.609090909090909
Gender type,division of geopolitical entity,0.569047619047619
Gender type,action specification,0.5790322580645162
Gender type,immunoglobulin complex,0.6015151515151516
Gender type,establishment of a clinically abnormal colony,0.5392857142857143
Gender type,incubation end temporal region,0.6207317073170732
Gender type,latency end process boundary,0.6038461538461539
Gender type,T cell receptor complex,0.6264705882352941
Gender type,B cell receptor complex,0.6264705882352941
Gender type,infection incidence rate,0.65
Gender type,infection end temporal region,0.625
Gender type,complex infection,0.5928571428571429
Gender type,infectious disease incidence rate,0.609090909090909
Gender type,communicability end temporal region,0.6021739130434782
InfectedViaJob,establishment of a clinically abnormal colony,0.5686440677966101
InfectedViaJob,infected population,0.7530303030303032
InfectedViaJob,T cell receptor complex,0.5581081081081081
InfectedViaJob,B cell receptor complex,0.5581081081081081
Mild and very mild COVID-19,incubation end process boundary,0.6224137931034482
Mild and very mild COVID-19,site,0.5145161290322581
Mild and very mild COVID-19,source of infection site,0.5676470588235294
Mild and very mild COVID-19,infection incidence rate profile,0.6025423728813559
Mild and very mild COVID-19,latency end temporal region,0.6351851851851852
Mild and very mild COVID-19,communicability end process boundary,0.6246031746031746
Mild and very mild COVID-19,infectious disease mortality rate,0.5833333333333334
Mild and very mild COVID-19,colonization of human,0.575
Mild and very mild COVID-19,establishment of a clinically abnormal colony,0.6166666666666667
Mild and very mild COVID-19,incubation end temporal region,0.6254385964912281
Mild and very mild COVID-19,pathogen portal of entry site,0.5928571428571429
Mild and very mild COVID-19,latency end process boundary,0.6318181818181818
Mild and very mild COVID-19,T cell receptor complex,0.59
Mild and very mild COVID-19,ribonucleic acid,0.636046511627907
Mild and very mild COVID-19,pathogen portal of exit site,0.5954545454545455
Mild and very mild COVID-19,B cell receptor complex,0.59
Mild and very mild COVID-19,site of infection,0.5863636363636363
Mild and very mild COVID-19,infection incidence rate,0.6068627450980393
Mild and very mild COVID-19,infection end temporal region,0.6285714285714286
Mild and very mild COVID-19,active immunization against infectious agent,0.5767605633802817
Mild and very mild COVID-19,infectious human pathogen,0.5846153846153846
Mild and very mild COVID-19,nucleic acid,0.6294871794871795
Mild and very mild COVID-19,infectious disease incidence rate,0.6
Mild and very mild COVID-19,communicability end temporal region,0.6435483870967742
Mild and very mild COVID-19,deoxyribonucleic acid,0.6375
InfectedNeighbor,infected population,0.7357142857142857
InfectedNeighbor,T cell receptor complex,0.5782051282051281
InfectedNeighbor,B cell receptor complex,0.5782051282051281
Covid Care Centre (CCC),case isolation control strategy,0.6351851851851852
Covid Care Centre (CCC),quarantine control strategy,0.63
Covid Care Centre (CCC),incubation end process boundary,0.6166666666666667
Covid Care Centre (CCC),latency end temporal region,0.61
Covid Care Centre (CCC),communicability end process boundary,0.6364406779661017
Covid Care Centre (CCC),infectious disease control strategy,0.6396551724137931
Covid Care Centre (CCC),herd immunity to infectious organism,0.5516949152542373
Covid Care Centre (CCC),pathogen portal of exit role,0.6068627450980393
Covid Care Centre (CCC),vector control strategy,0.6456521739130434
Covid Care Centre (CCC),action specification,0.5895348837209302
Covid Care Centre (CCC),place closure control strategy,0.6575471698113208
Covid Care Centre (CCC),establishment of a clinically abnormal colony,0.5823529411764706
Covid Care Centre (CCC),incubation end temporal region,0.619811320754717
Covid Care Centre (CCC),latency end process boundary,0.6068627450980393
Covid Care Centre (CCC),pathogen portal of exit,0.5804347826086956
Covid Care Centre (CCC),T cell receptor complex,0.6673913043478261
Covid Care Centre (CCC),pathogen portal of exit site,0.5872549019607843
Covid Care Centre (CCC),B cell receptor complex,0.6673913043478261
Covid Care Centre (CCC),infection end temporal region,0.6038461538461539
Covid Care Centre (CCC),communicability end temporal region,0.6396551724137931
Covid Care Centre (CCC),infectious disease control objective specification,0.6417808219178082
Doctor,incubation end process boundary,0.5851351351351352
Doctor,infection incidence rate profile,0.5552631578947369
Doctor,latency end temporal region,0.5712121212121213
Doctor,communicability end process boundary,0.569047619047619
Doctor,infectious disease mortality rate,0.5525641025641026
Doctor,plan specification,0.575
Doctor,establishment of a clinically abnormal colony,0.5284313725490196
Doctor,incubation end temporal region,0.5611111111111111
Doctor,latency end process boundary,0.5970588235294118
Doctor,T cell receptor complex,0.5879310344827586
Doctor,B cell receptor complex,0.5879310344827586
Doctor,infection incidence rate,0.5833333333333334
Doctor,infection end temporal region,0.5642857142857143
Doctor,infectious disease incidence rate,0.5525641025641026
Doctor,communicability end temporal region,0.5719512195121951
Vital signs,pathogen death temporal region,0.5963414634146341
Vital signs,primary infection role,0.6015151515151516
Vital signs,incubation end process boundary,0.569047619047619
Vital signs,site,0.5833333333333334
Vital signs,source of infection site,0.5928571428571429
Vital signs,primary infectious disposition,0.5963414634146341
Vital signs,infection incidence rate profile,0.5662790697674418
Vital signs,latency end temporal region,0.6078947368421053
Vital signs,communicability end process boundary,0.5776595744680851
Vital signs,infectious disease mortality rate,0.5636363636363636
Vital signs,generative stage,0.5981481481481481
Vital signs,infectious agent generative stage,0.609090909090909
Vital signs,infectious structure generative stage,0.5958333333333333
Vital signs,primary infection,0.6285714285714286
Vital signs,blood,0.5125
Vital signs,establishment of a clinically abnormal colony,0.5571428571428572
Vital signs,symptom,0.5055555555555555
Vital signs,incubation end temporal region,0.6207317073170732
Vital signs,primary pathogen,0.6351851851851852
Vital signs,pathogen portal of entry site,0.6
Vital signs,process that results in death,0.6
Vital signs,latency end process boundary,0.5525641025641026
Vital signs,T cell receptor complex,0.5382352941176471
Vital signs,pathogen portal of exit site,0.6038461538461539
Vital signs,B cell receptor complex,0.5088235294117647
Vital signs,site of infection,0.6285714285714286
Vital signs,infection incidence rate,0.5928571428571429
Vital signs,pathogen generative stage,0.5888888888888889
Vital signs,infection end temporal region,0.625
Vital signs,active immunization against infectious agent,0.5954545454545455
Vital signs,pathogen death process boundary,0.569047619047619
Vital signs,infectious disease incidence rate,0.5863636363636363
Vital signs,communicability end temporal region,0.6021739130434782
Vital signs,primary immunodeficiency,0.5928571428571429
City,infectious disease course,0.5189655172413793
City,acute infectious disease course,0.5357142857142857
City,local infection,0.6078947368421053
City,division of geopolitical entity,0.5642857142857143
City,place closure control strategy,0.5382352941176471
City,establishment of a clinically abnormal colony,0.5112244897959184
City,T cell receptor complex,0.524074074074074
City,B cell receptor complex,0.524074074074074
City,disease course,0.5055555555555555
City,chronic infectious disease course,0.5310810810810811
City,complex infection,0.5928571428571429
Business,organism substance,0.6038461538461539
Business,entry into host through host barriers,0.5611111111111111
Business,incubation end process boundary,0.6038461538461539
Business,surveillance process,0.6642857142857143
Business,function,0.6375
Business,invasion factor,0.5804347826086956
Business,specifically dependent continuant,0.5475609756097561
Business,incubation start process boundary,0.5963414634146341
Business,source of infection role,0.575
Business,planned process,0.6239130434782608
Business,droplet pathogen transmission process,0.5833333333333334
Business,source of infection site,0.60625
Business,negative regulation of immune response,0.5804347826086956
Business,latency end temporal region,0.5071428571428571
Business,process boundary,0.575
Business,communicability end process boundary,0.5863636363636363
Business,negative regulation of developmental process,0.5653846153846154
Business,negative regulation of establishment of localization,0.55
Business,humoral immune response,0.6435483870967742
Business,production,0.6166666666666667
Business,horizontal pathogen transmission process,0.575
Business,source of infection,0.5981481481481481
Business,virulence factor,0.575
Business,indirect pathogen transmission process,0.5804347826086956
Business,symbiotic process,0.65
Business,communicability start process boundary,0.558695652173913
Business,developmental process,0.5879310344827586
Business,plan specification,0.5653846153846154
Business,adhesion factor,0.5804347826086956
Business,action specification,0.5571428571428572
Business,establishment of a clinically abnormal colony,0.5254716981132076
Business,infection start process boundary,0.575
Business,virulence factor disposition,0.5888888888888889
Business,incubation end temporal region,0.5552631578947369
Business,pathogen birth process boundary,0.5782051282051281
Business,innate immune response,0.6166666666666667
Business,contact pathogen transmission process,0.5833333333333334
Business,biological process,0.6423076923076922
Business,process,0.65
Business,pathogen portal of entry role,0.504054054054054
Business,negative regulation of production,0.523170731707317
Business,pathogen portal of entry site,0.5310810810810811
Business,process that results in death,0.5851351351351352
Business,latency end process boundary,0.5611111111111111
Business,process of establishing an infection,0.5636363636363636
Business,adaptive immune response,0.60625
Business,entry into host,0.5804347826086956
Business,establishment of localization,0.5581081081081081
Business,negative regulation of biological process,0.5724489795918367
Business,immune response,0.6673913043478261
Business,generically dependent continuant,0.525
Business,B cell receptor complex,0.5145161290322581
Business,establishment of localization in host,0.5611111111111111
Business,pathogen portal of entry,0.5125
Business,process profile,0.5804347826086956
Business,infection end temporal region,0.5310810810810811
Business,negative regulation of viral process,0.5863636363636363
Business,latency start process boundary,0.5552631578947369
Business,pathogen death process boundary,0.5525641025641026
Business,communicability end temporal region,0.5430232558139535
Business,pathogen transmission process,0.6121621621621621
Business,negative regulation of life-sustaining process,0.5796296296296296
Dedicated Covid Hospital (DCH),hospital facility,0.6627659574468084
Dedicated Covid Hospital (DCH),incubation end process boundary,0.630327868852459
Dedicated Covid Hospital (DCH),infection incidence rate profile,0.6274193548387097
Dedicated Covid Hospital (DCH),latency end temporal region,0.6254385964912281
Dedicated Covid Hospital (DCH),communicability end process boundary,0.6166666666666667
Dedicated Covid Hospital (DCH),infectious disease mortality rate,0.6246031746031746
Dedicated Covid Hospital (DCH),negative regulation of establishment of localization,0.6207317073170732
Dedicated Covid Hospital (DCH),place closure control strategy,0.6166666666666667
Dedicated Covid Hospital (DCH),establishment of a clinically abnormal colony,0.61
Dedicated Covid Hospital (DCH),incubation end temporal region,0.6333333333333333
Dedicated Covid Hospital (DCH),latency end process boundary,0.6224137931034482
Dedicated Covid Hospital (DCH),T cell receptor complex,0.619811320754717
Dedicated Covid Hospital (DCH),establishment of localization,0.6025423728813559
Dedicated Covid Hospital (DCH),B cell receptor complex,0.619811320754717
Dedicated Covid Hospital (DCH),establishment of localization in host,0.6291044776119403
Dedicated Covid Hospital (DCH),infection incidence rate,0.6166666666666667
Dedicated Covid Hospital (DCH),infection end temporal region,0.6194915254237288
Dedicated Covid Hospital (DCH),active immunization against infectious agent,0.5851351351351352
Dedicated Covid Hospital (DCH),infectious disease incidence rate,0.6246031746031746
Dedicated Covid Hospital (DCH),communicability end temporal region,0.6192307692307693
Country,pathogen death temporal region,0.5581081081081081
Country,infection incidence proportion profile,0.5611111111111111
Country,zero-dimensional temporal region,0.5525641025641026
Country,incubation end process boundary,0.6078947368421053
Country,communicability start temporal region,0.5863636363636363
Country,one-dimensional spatial region,0.5581081081081081
Country,zero-dimensional spatial region,0.5552631578947369
Country,spatiotemporal region,0.5571428571428572
Country,infection incidence rate profile,0.5782051282051281
Country,latency end temporal region,0.5676470588235294
Country,communicability end process boundary,0.6127906976744186
Country,infectious disease mortality rate,0.575
Country,temporal region,0.5409090909090909
Country,two-dimensional spatial region,0.5581081081081081
Country,cell space,0.5088235294117647
Country,infection incidence proportion,0.5581081081081081
Country,spatial region,0.5452380952380953
Country,infection start temporal region,0.581578947368421
Country,one-dimensional temporal region,0.5552631578947369
Country,country,0.95
Country,establishment of a clinically abnormal colony,0.5269230769230769
Country,incubation end temporal region,0.5851351351351352
Country,geographical region,0.5653846153846154
Country,latency end process boundary,0.6214285714285714
Country,T cell receptor complex,0.55
Country,anatomical space,0.5369565217391304
Country,B cell receptor complex,0.55
Country,infection incidence rate,0.5790322580645162
Country,infection end temporal region,0.5888888888888889
Country,simple infection,0.5804347826086956
Country,infectious disease incidence proportion,0.558695652173913
Country,three-dimensional spatial region,0.5525641025641026
Country,infectious disease incidence rate,0.575
Country,communicability end temporal region,0.5928571428571429
Country,pathogen birth temporal region,0.5581081081081081
Country,geospatial region,0.575
Professional nurse,incubation end process boundary,0.6540816326530612
Professional nurse,latency end temporal region,0.6055555555555556
Professional nurse,communicability end process boundary,0.6351851851851852
Professional nurse,negative regulation of establishment of localization,0.5928571428571429
Professional nurse,establishment of a clinically abnormal colony,0.6087301587301588
Professional nurse,incubation end temporal region,0.6166666666666667
Professional nurse,latency end process boundary,0.6673913043478261
Professional nurse,T cell receptor complex,0.5719512195121951
Professional nurse,establishment of localization,0.598936170212766
Professional nurse,B cell receptor complex,0.5719512195121951
Professional nurse,establishment of localization in host,0.6136363636363636
Professional nurse,infection end temporal region,0.6627659574468084
Professional nurse,communicability end temporal region,0.6009433962264151
Nurse,incubation end process boundary,0.5611111111111111
Nurse,latency end temporal region,0.54375
Nurse,communicability end process boundary,0.523170731707317
Nurse,incubation end temporal region,0.5642857142857143
Nurse,latency end process boundary,0.5409090909090909
Nurse,T cell receptor complex,0.5214285714285714
Nurse,B cell receptor complex,0.5214285714285714
Nurse,infection end temporal region,0.5382352941176471
Nurse,communicability end temporal region,0.525
District wise statistics,pathogen death temporal region,0.5796296296296296
District wise statistics,diseased population,0.6593023255813953
District wise statistics,zero-dimensional temporal region,0.5928571428571429
District wise statistics,incubation end process boundary,0.5954545454545455
District wise statistics,communicability start temporal region,0.6139344262295081
District wise statistics,infectious disease course,0.6744897959183673
District wise statistics,one-dimensional spatial region,0.6351851851851852
District wise statistics,susceptible population,0.6456521739130434
District wise statistics,zero-dimensional spatial region,0.6318181818181818
District wise statistics,infectious agent colony,0.6414893617021277
District wise statistics,normal resident microbiota population,0.5975409836065574
District wise statistics,source of infection role,0.6166666666666667
District wise statistics,spatiotemporal region,0.6055555555555556
District wise statistics,source of infection site,0.6583333333333334
District wise statistics,latency end temporal region,0.6068627450980393
District wise statistics,communicability end process boundary,0.5833333333333334
District wise statistics,temporal region,0.5782051282051281
District wise statistics,two-dimensional spatial region,0.6351851851851852
District wise statistics,source of infection,0.636046511627907
District wise statistics,long-term non-progressing infectious disease course,0.6233333333333334
District wise statistics,designative information content entity,0.6435483870967742
District wise statistics,material entity,0.6551282051282051
District wise statistics,acute infectious disease course,0.6681818181818181
District wise statistics,spatial region,0.6078947368421053
District wise statistics,infection start temporal region,0.65
District wise statistics,one-dimensional temporal region,0.5954545454545455
District wise statistics,local infection,0.6038461538461539
District wise statistics,plan specification,0.5928571428571429
District wise statistics,infectious agent population,0.6460784313725491
District wise statistics,establishment of a clinically abnormal colony,0.5949275362318841
District wise statistics,incubation end temporal region,0.6166666666666667
District wise statistics,geographical region,0.5895348837209302
District wise statistics,directive information content entity,0.6666666666666667
District wise statistics,process that results in death,0.6386792452830189
District wise statistics,infected population,0.636046511627907
District wise statistics,latency end process boundary,0.5846153846153846
District wise statistics,T cell receptor complex,0.5776595744680851
District wise statistics,organism population,0.6127906976744186
District wise statistics,B cell receptor complex,0.5563829787234043
District wise statistics,material processing,0.636046511627907
District wise statistics,processed material,0.6404761904761905
District wise statistics,disease course,0.6605263157894737
District wise statistics,descriptive information content entity,0.6596774193548387
District wise statistics,chronic infectious disease course,0.6605263157894737
District wise statistics,infection end temporal region,0.619811320754717
District wise statistics,immune population,0.5963414634146341
District wise statistics,information content entity,0.65
District wise statistics,active immunization against infectious agent,0.6411764705882353
District wise statistics,three-dimensional spatial region,0.6285714285714286
District wise statistics,communicability end temporal region,0.6025423728813559
District wise statistics,pathogen birth temporal region,0.5796296296296296
District wise statistics,geospatial region,0.5963414634146341
District wise statistics,acute infection,0.6294871794871795
Status,generative stage,0.5863636363636363
Status,infectious agent generative stage,0.5782051282051281
Status,infectious structure generative stage,0.5662790697674418
Status,action specification,0.5653846153846154
Status,place closure control strategy,0.5611111111111111
Status,establishment of a clinically abnormal colony,0.5284313725490196
Status,T cell receptor complex,0.5189655172413793
Status,pathogen generative stage,0.5790322580645162
Status,quality,0.6038461538461539
Province,pathogen death temporal region,0.5552631578947369
Province,biological vector role,0.5833333333333334
Province,symbiont role,0.5928571428571429
Province,pathogen vector role,0.6285714285714286
Province,case isolation control strategy,0.5782051282051281
Province,primary infection role,0.65
Province,asymptomatic carrier role,0.6015151515151516
Province,zero-dimensional temporal region,0.575
Province,incubation end process boundary,0.5782051282051281
Province,communicability start temporal region,0.5388888888888889
Province,one-dimensional spatial region,0.5552631578947369
Province,function,0.575
Province,fomite role,0.6078947368421053
Province,secondary infection role,0.60625
Province,pathogen host role,0.6038461538461539
Province,zero-dimensional spatial region,0.5782051282051281
Province,definitive host role,0.5571428571428572
Province,infectious agent colony,0.5790322580645162
Province,parasite role,0.6404761904761905
Province,source of infection role,0.6375
Province,symbiont host role,0.5653846153846154
Province,spatiotemporal region,0.5879310344827586
Province,source of infection site,0.6375
Province,infection incidence rate profile,0.575
Province,latency end temporal region,0.5642857142857143
Province,communicability end process boundary,0.5636363636363636
Province,infectious disease mortality rate,0.5475609756097561
Province,temporal region,0.6239130434782608
Province,two-dimensional spatial region,0.5552631578947369
Province,source of infection,0.6351851851851852
Province,reservoir of pathogen role,0.5970588235294118
Province,mutualist role,0.5863636363636363
Province,pathogen portal of exit role,0.5888888888888889
Province,dead-end host role,0.5653846153846154
Province,pathogen vehicle role,0.656896551724138
Province,spatial region,0.6318181818181818
Province,infection start temporal region,0.5525641025641026
Province,commensal role,0.5863636363636363
Province,one-dimensional temporal region,0.5525641025641026
Province,symptomatic carrier role,0.60625
Province,division of geopolitical entity,0.5782051282051281
Province,action specification,0.5571428571428572
Province,intermediate host role,0.55
Province,establishment of a clinically abnormal colony,0.5254716981132076
Province,incubation end temporal region,0.5552631578947369
Province,geographical region,0.5981481481481481
Province,host role,0.6264705882352941
Province,reagent role,0.6
Province,pathogen portal of entry role,0.5851351351351352
Province,latency end process boundary,0.5888888888888889
Province,mechanical vector role,0.55
Province,T cell receptor complex,0.5790322580645162
Province,biological vehicle role,0.6112903225806451
Province,infectious structure host role,0.5552631578947369
Province,B cell receptor complex,0.5790322580645162
Province,colony,0.5928571428571429
Province,biological role,0.6239130434782608
Province,infection incidence rate,0.60625
Province,infection end temporal region,0.5581081081081081
Province,role,0.7
Province,infectious agent host role,0.5676470588235294
Province,three-dimensional spatial region,0.55
Province,infectious disease incidence rate,0.5719512195121951
Province,communicability end temporal region,0.5430232558139535
Province,pathogen birth temporal region,0.581578947368421
Province,quality,0.5166666666666666
Province,geospatial region,0.61
Province,pathogen transporter role,0.5712121212121213
Symptom,infectious disposition,0.5879310344827586
Symptom,fungicidal disposition,0.5879310344827586
Symptom,collective pathogenic disposition,0.55
Symptom,immunosuppressive disposition,0.5611111111111111
Symptom,incubation end process boundary,0.5026315789473684
Symptom,disease transmission model,0.5712121212121213
Symptom,macromolecular complex,0.553448275862069
Symptom,collective resistance disposition,0.55
Symptom,adhesion disposition,0.5981481481481481
Symptom,bactericidal disposition,0.5790322580645162
Symptom,static agent disposition,0.5790322580645162
Symptom,toxin disposition,0.6166666666666667
Symptom,primary infectious disposition,0.5581081081081081
Symptom,bacteriostatic disposition,0.5712121212121213
Symptom,latency end temporal region,0.5676470588235294
Symptom,communicability end process boundary,0.5197674418604651
Symptom,disposition,0.6722222222222223
Symptom,invasive disposition,0.5981481481481481
Symptom,designative information content entity,0.5388888888888889
Symptom,parasitostatic disposition,0.5712121212121213
Symptom,pathogenic disposition,0.5879310344827586
Symptom,immunoglobulin complex,0.553448275862069
Symptom,establishment of a clinically abnormal colony,0.5461538461538461
Symptom,transmissibility disposition,0.5928571428571429
Symptom,virulence factor disposition,0.5642857142857143
Symptom,symptom,0.95
Symptom,incubation end temporal region,0.5310810810810811
Symptom,exotoxin disposition,0.5981481481481481
Symptom,opportunistic infectious disposition,0.5430232558139535
Symptom,directive information content entity,0.5197674418604651
Symptom,fungistatic disposition,0.5833333333333334
Symptom,latency end process boundary,0.5357142857142857
Symptom,cytotoxin disposition,0.5928571428571429
Symptom,T cell receptor complex,0.5833333333333334
Symptom,cidal agent disposition,0.5833333333333334
Symptom,zoonotic disposition,0.5981481481481481
Symptom,B cell receptor complex,0.5833333333333334
Symptom,endotoxin disposition,0.5928571428571429
Symptom,descriptive information content entity,0.5611111111111111
Symptom,invasion disposition,0.5981481481481481
Symptom,infection end temporal region,0.5333333333333333
Symptom,information content entity,0.5409090909090909
Symptom,enterotoxin disposition,0.5833333333333334
Symptom,parasiticidal disposition,0.575
Symptom,complex infection,0.6166666666666667
Symptom,communicability end temporal region,0.5452380952380953
Symptom,neurotoxin disposition,0.5879310344827586
Symptom,quality,0.5214285714285714
Symptom,reverse zoonotic disposition,0.5642857142857143
Symptom,collective disposition,0.5879310344827586
Close contact,entry into host through host barriers,0.57
Close contact,systematic infection,0.6318181818181818
Close contact,contact tracing,0.7
Close contact,incubation end process boundary,0.6318181818181818
Close contact,infectious disease course,0.6342105263157894
Close contact,latency end temporal region,0.6
Close contact,communicability end process boundary,0.6132653061224489
Close contact,long-term non-progressing infectious disease course,0.590625
Close contact,acute infectious disease course,0.609090909090909
Close contact,action specification,0.6621212121212122
Close contact,establishment of a clinically abnormal colony,0.5879310344827586
Close contact,incubation end temporal region,0.5895348837209302
Close contact,contact pathogen transmission process,0.61
Close contact,pathogen portal of entry role,0.6166666666666667
Close contact,pathogen portal of entry site,0.6166666666666667
Close contact,latency end process boundary,0.6207317073170732
Close contact,T cell receptor complex,0.6166666666666667
Close contact,entry into host,0.6285714285714286
Close contact,B cell receptor complex,0.6166666666666667
Close contact,pathogen portal of entry,0.6391891891891892
Close contact,disease course,0.6351851851851852
Close contact,chronic infectious disease course,0.6021739130434782
Close contact,infection end temporal region,0.5928571428571429
Close contact,communicability end temporal region,0.575
Diagnosed With COVID-19,place closure control strategy,0.5820754716981132
Diagnosed With COVID-19,establishment of a clinically abnormal colony,0.5676470588235294
Diagnosed With COVID-19,T cell receptor complex,0.5804347826086956
Agent,asymptomatic infectious agent carrier,0.569047619047619
Agent,asymptomatic carrier role,0.5166666666666666
Agent,incubation end process boundary,0.5333333333333333
Agent,immunization against infectious agent,0.569047619047619
Agent,infectious disease course,0.5166666666666666
Agent,function,0.6038461538461539
Agent,invasion factor,0.6
Agent,infectious agent colony,0.6285714285714286
Agent,static agent disposition,0.6224137931034482
Agent,cidal agent,0.7625
Agent,symptomatic carrier,0.5333333333333333
Agent,vaccination against infectious agent,0.5719512195121951
Agent,symptomatic infectious structure carrier,0.5166666666666666
Agent,passive immunization against infectious agent,0.55
Agent,infection incidence rate profile,0.5310810810810811
Agent,latency end temporal region,0.575
Agent,communicability end process boundary,0.523170731707317
Agent,infectious disease mortality rate,0.5289473684210526
Agent,passive immunity to infectious agent,0.5719512195121951
Agent,infectious agent host,0.6423076923076922
Agent,sterilizing immunity to infectious agent,0.5611111111111111
Agent,static agent,0.7441176470588234
Agent,drug susceptibility of infectious agent,0.5636363636363636
Agent,infectious agent generative stage,0.581578947368421
Agent,long-term non-progressing infectious disease course,0.5214285714285714
Agent,symptomatic infectious agent carrier,0.5719512195121951
Agent,designative information content entity,0.5430232558139535
Agent,virulence factor,0.5928571428571429
Agent,infectious agent,0.6880952380952381
Agent,humoral immunity to infectious agent,0.5719512195121951
Agent,acute infectious disease course,0.5611111111111111
Agent,pathogen vehicle role,0.6038461538461539
Agent,symptomatic carrier role,0.5189655172413793
Agent,leukocyte-mediated immunity to infectious agent,0.5461538461538461
Agent,adhesion factor,0.65
Agent,action specification,0.57
Agent,infectious agent population,0.60625
Agent,intermediate host role,0.5611111111111111
Agent,pathogen vehicle,0.6404761904761905
Agent,establishment of a clinically abnormal colony,0.53
Agent,virulence factor disposition,0.5409090909090909
Agent,incubation end temporal region,0.5642857142857143
Agent,pathogen transporter,0.65
Agent,acquired immunity to infectious agent,0.569047619047619
Agent,directive information content entity,0.5475609756097561
Agent,latency end process boundary,0.5409090909090909
Agent,T cell receptor complex,0.5214285714285714
Agent,cidal agent disposition,0.6285714285714286
Agent,infectious agent reservoir,0.6112903225806451
Agent,biological vehicle role,0.5214285714285714
Agent,intermediate host,0.5863636363636363
Agent,B cell receptor complex,0.5214285714285714
Agent,asymptomatic infectious structure carrier,0.5152173913043478
Agent,disease course,0.5552631578947369
Agent,descriptive information content entity,0.5430232558139535
Agent,chronic infectious disease course,0.5026315789473684
Agent,infection incidence rate,0.553448275862069
Agent,infection end temporal region,0.5382352941176471
Agent,information content entity,0.5790322580645162
Agent,infectious agent host role,0.6112903225806451
Agent,active immunization against infectious agent,0.5520408163265306
Agent,biological vehicle,0.5369565217391304
Agent,infectious disease incidence rate,0.5552631578947369
Agent,communicability end temporal region,0.55
Agent,innate immunity to infectious agent,0.575
Agent,pathogen transporter role,0.6166666666666667
Agent,asymptomatic carrier,0.53
Agent,susceptibility to infectious agent,0.5782051282051281
Clinical finding (finding),incubation end process boundary,0.6254385964912281
Clinical finding (finding),latency end temporal region,0.619811320754717
Clinical finding (finding),communicability end process boundary,0.6435483870967742
Clinical finding (finding),establishment of a clinically abnormal colony,0.6190140845070422
Clinical finding (finding),incubation end temporal region,0.6464285714285714
Clinical finding (finding),latency end process boundary,0.6166666666666667
Clinical finding (finding),T cell receptor complex,0.5520408163265306
Clinical finding (finding),B cell receptor complex,0.5520408163265306
Clinical finding (finding),infection end temporal region,0.6318181818181818
Clinical finding (finding),objective specification,0.6132653061224489
Clinical finding (finding),active immunization against infectious agent,0.65
Clinical finding (finding),communicability end temporal region,0.6467213114754098
Clinical finding (finding),disease surveillance objective specification,0.6071428571428572
Clinical finding (finding),infectious disease control objective specification,0.6078947368421053
Clinical finding (finding),object aggregate,0.5452380952380953
Disease caused by Coronaviridae,infection incidence proportion profile,0.6384057971014493
Disease caused by Coronaviridae,infectious disposition,0.619811320754717
Disease caused by Coronaviridae,fungicidal disposition,0.5820754716981132
Disease caused by Coronaviridae,collective pathogenic disposition,0.590625
Disease caused by Coronaviridae,primary infection role,0.619811320754717
Disease caused by Coronaviridae,systematic infection,0.6068627450980393
Disease caused by Coronaviridae,immunosuppressive disposition,0.6166666666666667
Disease caused by Coronaviridae,incubation end process boundary,0.6435483870967742
Disease caused by Coronaviridae,communicability start temporal region,0.6117647058823529
Disease caused by Coronaviridae,infectious disease course,0.6642857142857143
Disease caused by Coronaviridae,disease transmission model,0.6956140350877194
Disease caused by Coronaviridae,secondary infection role,0.65
Disease caused by Coronaviridae,collective resistance disposition,0.590625
Disease caused by Coronaviridae,adhesion disposition,0.6068627450980393
Disease caused by Coronaviridae,bactericidal disposition,0.5954545454545455
Disease caused by Coronaviridae,static agent disposition,0.6136363636363636
Disease caused by Coronaviridae,incubation start process boundary,0.6375
Disease caused by Coronaviridae,source of infection role,0.6318181818181818
Disease caused by Coronaviridae,community-acquired infection,0.6194915254237288
Disease caused by Coronaviridae,toxin disposition,0.575
Disease caused by Coronaviridae,secondary infection,0.63
Disease caused by Coronaviridae,source of infection site,0.6318181818181818
Disease caused by Coronaviridae,primary infectious disposition,0.6139344262295081
Disease caused by Coronaviridae,infection,0.575
Disease caused by Coronaviridae,infection incidence rate profile,0.6246031746031746
Disease caused by Coronaviridae,bacteriostatic disposition,0.5903508771929825
Disease caused by Coronaviridae,latency end temporal region,0.6396551724137931
Disease caused by Coronaviridae,communicability end process boundary,0.6291044776119403
Disease caused by Coronaviridae,infectious disease lifetime prevalence,0.6528985507246376
Disease caused by Coronaviridae,infectious disease mortality rate,0.684375
Disease caused by Coronaviridae,infectious disorder,0.65
Disease caused by Coronaviridae,disposition,0.5928571428571429
Disease caused by Coronaviridae,infectious disease control strategy,0.6772727272727272
Disease caused by Coronaviridae,infection incidence,0.63
Disease caused by Coronaviridae,infectious disease epidemic,0.656896551724138
Disease caused by Coronaviridae,appearance of disorder,0.6386792452830189
Disease caused by Coronaviridae,invasive disposition,0.6264705882352941
Disease caused by Coronaviridae,infection incidence profile,0.6224137931034482
Disease caused by Coronaviridae,source of infection,0.61
Disease caused by Coronaviridae,long-term non-progressing infectious disease course,0.5963414634146341
Disease caused by Coronaviridae,parasitostatic disposition,0.5903508771929825
Disease caused by Coronaviridae,infectious disease sporadicity,0.6795081967213115
Disease caused by Coronaviridae,infectious disease pandemic,0.656896551724138
Disease caused by Coronaviridae,communicability start process boundary,0.6239130434782608
Disease caused by Coronaviridae,acute infectious disease course,0.6435483870967742
Disease caused by Coronaviridae,infection incidence proportion,0.6139344262295081
Disease caused by Coronaviridae,infection start temporal region,0.6112903225806451
Disease caused by Coronaviridae,local infection,0.5804347826086956
Disease caused by Coronaviridae,pathogenic disposition,0.5820754716981132
Disease caused by Coronaviridae,primary infection,0.5958333333333333
Disease caused by Coronaviridae,infectious disease endemicity,0.65
Disease caused by Coronaviridae,disease,0.6342105263157894
Disease caused by Coronaviridae,establishment of a clinically abnormal colony,0.6342105263157894
Disease caused by Coronaviridae,transmissibility disposition,0.6025423728813559
Disease caused by Coronaviridae,extracellular infection,0.5981481481481481
Disease caused by Coronaviridae,infection start process boundary,0.6404761904761905
Disease caused by Coronaviridae,virulence factor disposition,0.6364406779661017
Disease caused by Coronaviridae,incubation end temporal region,0.630327868852459
Disease caused by Coronaviridae,hospital-acquired infection,0.6224137931034482
Disease caused by Coronaviridae,disorder,0.6294871794871795
Disease caused by Coronaviridae,exotoxin disposition,0.5676470588235294
Disease caused by Coronaviridae,infectious disease,0.6336734693877552
Disease caused by Coronaviridae,acquired immunity to infectious agent,0.6411764705882353
Disease caused by Coronaviridae,opportunistic infectious disposition,0.5992537313432835
Disease caused by Coronaviridae,fungistatic disposition,0.5981481481481481
Disease caused by Coronaviridae,chronic infection,0.5958333333333333
Disease caused by Coronaviridae,metastatic infection,0.6068627450980393
Disease caused by Coronaviridae,latency end process boundary,0.6364406779661017
Disease caused by Coronaviridae,process of establishing an infection,0.5992537313432835
Disease caused by Coronaviridae,cytotoxin disposition,0.5846153846153846
Disease caused by Coronaviridae,T cell receptor complex,0.6166666666666667
Disease caused by Coronaviridae,intracellular infection,0.5981481481481481
Disease caused by Coronaviridae,cidal agent disposition,0.6166666666666667
Disease caused by Coronaviridae,subclinical infection,0.6038461538461539
Disease caused by Coronaviridae,acquired immunodeficiency,0.6285714285714286
Disease caused by Coronaviridae,zoonotic disposition,0.5676470588235294
Disease caused by Coronaviridae,B cell receptor complex,0.6166666666666667
Disease caused by Coronaviridae,site of infection,0.5958333333333333
Disease caused by Coronaviridae,endotoxin disposition,0.5846153846153846
Disease caused by Coronaviridae,disease course,0.7166666666666667
Disease caused by Coronaviridae,infectious disease prevalence,0.65
Disease caused by Coronaviridae,chronic infectious disease course,0.6375
Disease caused by Coronaviridae,invasion disposition,0.6068627450980393
Disease caused by Coronaviridae,infection prevalence,0.6068627450980393
Disease caused by Coronaviridae,infection incidence rate,0.6318181818181818
Disease caused by Coronaviridae,infection end temporal region,0.6333333333333333
Disease caused by Coronaviridae,enterotoxin disposition,0.5796296296296296
Disease caused by Coronaviridae,parasiticidal disposition,0.5928571428571429
Disease caused by Coronaviridae,simple infection,0.598936170212766
Disease caused by Coronaviridae,complex infection,0.575
Disease caused by Coronaviridae,latency start process boundary,0.630327868852459
Disease caused by Coronaviridae,infectious disease incidence proportion,0.6642857142857143
Disease caused by Coronaviridae,infectious disease incidence rate,0.66875
Disease caused by Coronaviridae,communicability end temporal region,0.6166666666666667
Disease caused by Coronaviridae,neurotoxin disposition,0.5820754716981132
Disease caused by Coronaviridae,infectious disease incidence,0.6533898305084747
Disease caused by Coronaviridae,disease surveillance objective specification,0.6766666666666665
Disease caused by Coronaviridae,infectious disease control objective specification,0.6475308641975309
Disease caused by Coronaviridae,nursing-home acquired infection,0.6274193548387097
Disease caused by Coronaviridae,reverse zoonotic disposition,0.6194915254237288
Disease caused by Coronaviridae,acute infection,0.6239130434782608
Disease caused by Coronaviridae,collective disposition,0.5820754716981132
State wise statistics,diseased population,0.65
State wise statistics,case isolation control strategy,0.6423076923076922
State wise statistics,incubation end process boundary,0.5846153846153846
State wise statistics,site,0.57
State wise statistics,susceptible population,0.636046511627907
State wise statistics,normal resident microbiota population,0.6051724137931035
State wise statistics,source of infection role,0.6055555555555556
State wise statistics,source of infection site,0.65
State wise statistics,infection incidence rate profile,0.6009433962264151
State wise statistics,latency end temporal region,0.6375
State wise statistics,communicability end process boundary,0.5728070175438597
State wise statistics,infectious disease mortality rate,0.6351851851851852
State wise statistics,source of infection,0.625
State wise statistics,designative information content entity,0.6364406779661017
State wise statistics,material entity,0.6722222222222223
State wise statistics,acute infectious disease course,0.6807692307692308
State wise statistics,plan specification,0.6294871794871795
State wise statistics,infectious agent population,0.6166666666666667
State wise statistics,establishment of a clinically abnormal colony,0.6166666666666667
State wise statistics,incubation end temporal region,0.6068627450980393
State wise statistics,directive information content entity,0.6078947368421053
State wise statistics,pathogen portal of entry site,0.63
State wise statistics,process that results in death,0.65
State wise statistics,infected population,0.6
State wise statistics,latency end process boundary,0.6132653061224489
State wise statistics,T cell receptor complex,0.5863636363636363
State wise statistics,organism population,0.625
State wise statistics,pathogen portal of exit site,0.6336734693877552
State wise statistics,B cell receptor complex,0.5636363636363636
State wise statistics,material processing,0.65
State wise statistics,site of infection,0.6605263157894737
State wise statistics,processed material,0.6294871794871795
State wise statistics,descriptive information content entity,0.6194915254237288
State wise statistics,infection incidence rate,0.6055555555555556
State wise statistics,infection end temporal region,0.59
State wise statistics,immune population,0.6078947368421053
State wise statistics,information content entity,0.6202127659574468
State wise statistics,active immunization against infectious agent,0.65
State wise statistics,infectious disease incidence rate,0.6166666666666667
State wise statistics,communicability end temporal region,0.5928571428571429
State wise statistics,acute infection,0.6722222222222223
Dedicated Covid Health Centre (DCHC),incubation end process boundary,0.6291044776119403
Dedicated Covid Health Centre (DCHC),macromolecular complex,0.5879310344827586
Dedicated Covid Health Centre (DCHC),infection incidence rate profile,0.6411764705882353
Dedicated Covid Health Centre (DCHC),latency end temporal region,0.6404761904761905
Dedicated Covid Health Centre (DCHC),communicability end process boundary,0.6305555555555555
Dedicated Covid Health Centre (DCHC),infectious disease mortality rate,0.6384057971014493
Dedicated Covid Health Centre (DCHC),appearance of disorder,0.6051724137931035
Dedicated Covid Health Centre (DCHC),immunoglobulin complex,0.553448275862069
Dedicated Covid Health Centre (DCHC),establishment of a clinically abnormal colony,0.6104938271604938
Dedicated Covid Health Centre (DCHC),incubation end temporal region,0.6469696969696969
Dedicated Covid Health Centre (DCHC),latency end process boundary,0.621875
Dedicated Covid Health Centre (DCHC),object,0.5452380952380953
Dedicated Covid Health Centre (DCHC),T cell receptor complex,0.6533898305084747
Dedicated Covid Health Centre (DCHC),B cell receptor complex,0.6364406779661017
Dedicated Covid Health Centre (DCHC),infection incidence rate,0.65
Dedicated Covid Health Centre (DCHC),infection end temporal region,0.6346153846153847
Dedicated Covid Health Centre (DCHC),complex infection,0.5820754716981132
Dedicated Covid Health Centre (DCHC),active immunization against infectious agent,0.6125
Dedicated Covid Health Centre (DCHC),infectious disease incidence rate,0.6528985507246376
Dedicated Covid Health Centre (DCHC),communicability end temporal region,0.6330985915492958
Dedicated Covid Health Centre (DCHC),object aggregate,0.6038461538461539
District,pathogen death temporal region,0.5552631578947369
District,zero-dimensional temporal region,0.6
District,communicability start temporal region,0.5611111111111111
District,infectious disease course,0.5712121212121213
District,one-dimensional spatial region,0.6078947368421053
District,zero-dimensional spatial region,0.6038461538461539
District,infectious agent colony,0.5790322580645162
District,normal resident microbiota population,0.5611111111111111
District,spatiotemporal region,0.5879310344827586
District,latency end temporal region,0.5642857142857143
District,temporal region,0.5804347826086956
District,two-dimensional spatial region,0.6078947368421053
District,long-term non-progressing infectious disease course,0.5347457627118644
District,acute infectious disease course,0.5525641025641026
District,spatial region,0.6318181818181818
District,infection start temporal region,0.5782051282051281
District,one-dimensional temporal region,0.6038461538461539
District,local infection,0.5804347826086956
District,establishment of a clinically abnormal colony,0.5443396226415094
District,incubation end temporal region,0.5552631578947369
District,geographical region,0.5611111111111111
District,T cell receptor complex,0.5790322580645162
District,B cell receptor complex,0.5467741935483871
District,colony,0.5214285714285714
District,disease course,0.6318181818181818
District,chronic infectious disease course,0.5475609756097561
District,infection end temporal region,0.5581081081081081
District,three-dimensional spatial region,0.6
District,communicability end temporal region,0.5430232558139535
District,pathogen birth temporal region,0.5552631578947369
District,geospatial region,0.61
Test result,organism substance,0.6224137931034482
Test result,incubation end process boundary,0.6166666666666667
Test result,communicability start temporal region,0.575
Test result,incubation start process boundary,0.6318181818181818
Test result,negative regulation of immune response,0.6132653061224489
Test result,infection incidence rate profile,0.5895348837209302
Test result,latency end temporal region,0.6078947368421053
Test result,communicability end process boundary,0.598936170212766
Test result,infectious disease mortality rate,0.609090909090909
Test result,humoral immune response,0.5970588235294118
Test result,production,0.5928571428571429
Test result,communicability start process boundary,0.6132653061224489
Test result,infection start temporal region,0.5928571428571429
Test result,plan specification,0.553448275862069
Test result,division of geopolitical entity,0.569047619047619
Test result,action specification,0.5790322580645162
Test result,place closure control strategy,0.5963414634146341
Test result,establishment of a clinically abnormal colony,0.5571428571428572
Test result,infection start process boundary,0.636046511627907
Test result,incubation end temporal region,0.5963414634146341
Test result,innate immune response,0.6318181818181818
Test result,negative regulation of production,0.6318181818181818
Test result,latency end process boundary,0.6294871794871795
Test result,adaptive immune response,0.6214285714285714
Test result,T cell receptor complex,0.6264705882352941
Test result,immune response,0.6423076923076922
Test result,B cell receptor complex,0.5970588235294118
Test result,infection incidence rate,0.5928571428571429
Test result,infection end temporal region,0.6
Test result,latency start process boundary,0.6695121951219513
Test result,infectious disease incidence rate,0.5863636363636363
Test result,communicability end temporal region,0.5804347826086956
Test result,assay,0.575
Anniversary,incubation end process boundary,0.6404761904761905
Anniversary,latency end temporal region,0.6342105263157894
Anniversary,communicability end process boundary,0.6202127659574468
Anniversary,establishment of a clinically abnormal colony,0.575
Anniversary,incubation end temporal region,0.6207317073170732
Anniversary,pathogen birth process boundary,0.6404761904761905
Anniversary,latency end process boundary,0.6551282051282051
Anniversary,T cell receptor complex,0.5382352941176471
Anniversary,B cell receptor complex,0.5382352941176471
Anniversary,infection end temporal region,0.6
Anniversary,communicability end temporal region,0.5804347826086956
Anniversary,pathogen birth temporal region,0.6207317073170732
Medical clinic,hospital facility,0.6758064516129032
Medical clinic,pathologic immunosuppression,0.5928571428571429
Medical clinic,infection incidence rate profile,0.6021739130434782
Medical clinic,infectious disease mortality rate,0.598936170212766
Medical clinic,negative regulation of establishment of localization,0.5863636363636363
Medical clinic,establishment of a clinically abnormal colony,0.6194915254237288
Medical clinic,T cell receptor complex,0.5851351351351352
Medical clinic,establishment of localization,0.636046511627907
Medical clinic,B cell receptor complex,0.5851351351351352
Medical clinic,establishment of localization in host,0.6264705882352941
Medical clinic,infection incidence rate,0.6342105263157894
Medical clinic,infectious disease incidence rate,0.6414893617021277
Severe COVID-19,systematic infection,0.5928571428571429
Severe COVID-19,incubation end process boundary,0.5804347826086956
Severe COVID-19,site,0.5552631578947369
Severe COVID-19,source of infection site,0.6294871794871795
Severe COVID-19,infection incidence rate profile,0.598936170212766
Severe COVID-19,latency end temporal region,0.569047619047619
Severe COVID-19,communicability end process boundary,0.5676470588235294
Severe COVID-19,infectious disease mortality rate,0.575
Severe COVID-19,acute infectious disease course,0.5804347826086956
Severe COVID-19,establishment of a clinically abnormal colony,0.55
Severe COVID-19,incubation end temporal region,0.5611111111111111
Severe COVID-19,pathogen portal of entry site,0.5636363636363636
Severe COVID-19,latency end process boundary,0.6127906976744186
Severe COVID-19,T cell receptor complex,0.6078947368421053
Severe COVID-19,pathogen portal of exit site,0.5662790697674418
Severe COVID-19,B cell receptor complex,0.6078947368421053
Severe COVID-19,site of infection,0.60625
Severe COVID-19,infection incidence rate,0.5782051282051281
Severe COVID-19,infection end temporal region,0.5636363636363636
Severe COVID-19,simple infection,0.6112903225806451
Severe COVID-19,infectious disease incidence rate,0.5958333333333333
Severe COVID-19,communicability end temporal region,0.55
Severe COVID-19,acute infection,0.5833333333333334
Laboratory test finding,primary infection role,0.65
Laboratory test finding,incubation end process boundary,0.6351851851851852
Laboratory test finding,invasion factor,0.6078947368421053
Laboratory test finding,primary infectious disposition,0.6575471698113208
Laboratory test finding,infection incidence rate profile,0.5954545454545455
Laboratory test finding,latency end temporal region,0.65
Laboratory test finding,communicability end process boundary,0.6194915254237288
Laboratory test finding,negative regulation of developmental process,0.5843283582089552
Laboratory test finding,infectious disease mortality rate,0.6107142857142857
Laboratory test finding,generative stage,0.6294871794871795
Laboratory test finding,infectious agent generative stage,0.6107142857142857
Laboratory test finding,virulence factor,0.5782051282051281
Laboratory test finding,infectious structure generative stage,0.6166666666666667
Laboratory test finding,developmental process,0.5863636363636363
Laboratory test finding,division of geopolitical entity,0.5981481481481481
Laboratory test finding,adhesion factor,0.6078947368421053
Laboratory test finding,primary infection,0.675
Laboratory test finding,establishment of a clinically abnormal colony,0.5970588235294118
Laboratory test finding,virulence factor disposition,0.6460784313725491
Laboratory test finding,incubation end temporal region,0.6386792452830189
Laboratory test finding,primary pathogen,0.6551282051282051
Laboratory test finding,latency end process boundary,0.6460784313725491
Laboratory test finding,T cell receptor complex,0.6021739130434782
Laboratory test finding,B cell receptor complex,0.6021739130434782
Laboratory test finding,infection incidence rate,0.598936170212766
Laboratory test finding,pathogen generative stage,0.6375
Laboratory test finding,infection end temporal region,0.6038461538461539
Laboratory test finding,infectious disease incidence rate,0.6285714285714286
Laboratory test finding,communicability end temporal region,0.6224137931034482
Laboratory test finding,primary immunodeficiency,0.6627659574468084
Laboratory test finding,assay,0.5571428571428572
Disease,infection incidence proportion profile,0.5166666666666666
Disease,infectious disposition,0.5879310344827586
Disease,fungicidal disposition,0.5879310344827586
Disease,collective pathogenic disposition,0.55
Disease,primary infection role,0.553448275862069
Disease,systematic infection,0.5981481481481481
Disease,immunosuppressive disposition,0.5888888888888889
Disease,incubation end process boundary,0.5289473684210526
Disease,infectious disease course,0.66875
Disease,disease transmission model,0.6621212121212122
Disease,secondary infection role,0.5790322580645162
Disease,collective resistance disposition,0.55
Disease,adhesion disposition,0.5981481481481481
Disease,bactericidal disposition,0.5790322580645162
Disease,static agent disposition,0.5790322580645162
Disease,source of infection role,0.5467741935483871
Disease,community-acquired infection,0.5357142857142857
Disease,toxin disposition,0.6166666666666667
Disease,secondary infection,0.6038461538461539
Disease,source of infection site,0.5790322580645162
Disease,primary infectious disposition,0.5581081081081081
Disease,infection,0.575
Disease,infection incidence rate profile,0.5525641025641026
Disease,bacteriostatic disposition,0.5712121212121213
Disease,latency end temporal region,0.5676470588235294
Disease,communicability end process boundary,0.5197674418604651
Disease,infectious disease lifetime prevalence,0.6055555555555556
Disease,infectious disease mortality rate,0.625
Disease,infectious disorder,0.6038461538461539
Disease,disposition,0.6722222222222223
Disease,infectious disease control strategy,0.6166666666666667
Disease,infection incidence,0.5653846153846154
Disease,infectious disease epidemic,0.6558823529411765
Disease,appearance of disorder,0.5879310344827586
Disease,invasive disposition,0.5981481481481481
Disease,infection incidence profile,0.5382352941176471
Disease,source of infection,0.5653846153846154
Disease,long-term non-progressing infectious disease course,0.5706896551724138
Disease,parasitostatic disposition,0.5712121212121213
Disease,infectious disease sporadicity,0.6391891891891892
Disease,infectious disease pandemic,0.6558823529411765
Disease,acute infectious disease course,0.6342105263157894
Disease,infection incidence proportion,0.5310810810810811
Disease,infection start temporal region,0.581578947368421
Disease,local infection,0.5409090909090909
Disease,pathogenic disposition,0.5879310344827586
Disease,primary infection,0.575
Disease,infectious disease endemicity,0.6444444444444444
Disease,disease,0.95
Disease,establishment of a clinically abnormal colony,0.5269230769230769
Disease,transmissibility disposition,0.5642857142857143
Disease,extracellular infection,0.55
Disease,infection start process boundary,0.5525641025641026
Disease,virulence factor disposition,0.5642857142857143
Disease,incubation end temporal region,0.5581081081081081
Disease,hospital-acquired infection,0.5382352941176471
Disease,disorder,0.7166666666666667
Disease,exotoxin disposition,0.5981481481481481
Disease,infectious disease,0.73
Disease,opportunistic infectious disposition,0.5430232558139535
Disease,fungistatic disposition,0.5833333333333334
Disease,chronic infection,0.5333333333333333
Disease,metastatic infection,0.5981481481481481
Disease,latency end process boundary,0.5357142857142857
Disease,process of establishing an infection,0.5662790697674418
Disease,cytotoxin disposition,0.5928571428571429
Disease,T cell receptor complex,0.5166666666666666
Disease,intracellular infection,0.5833333333333334
Disease,cidal agent disposition,0.5833333333333334
Disease,subclinical infection,0.5571428571428572
Disease,zoonotic disposition,0.5981481481481481
Disease,B cell receptor complex,0.5166666666666666
Disease,site of infection,0.575
Disease,endotoxin disposition,0.5928571428571429
Disease,disease course,0.7833333333333333
Disease,infectious disease prevalence,0.6444444444444444
Disease,chronic infectious disease course,0.625
Disease,invasion disposition,0.5981481481481481
Disease,infection prevalence,0.5981481481481481
Disease,infection incidence rate,0.5790322580645162
Disease,infection end temporal region,0.5611111111111111
Disease,enterotoxin disposition,0.5833333333333334
Disease,parasiticidal disposition,0.575
Disease,simple infection,0.5804347826086956
Disease,complex infection,0.5333333333333333
Disease,infectious disease incidence proportion,0.6021739130434782
Disease,infectious disease incidence rate,0.625
Disease,communicability end temporal region,0.5452380952380953
Disease,neurotoxin disposition,0.5879310344827586
Disease,infectious disease incidence,0.65
Disease,disease surveillance objective specification,0.5872549019607843
Disease,infectious disease control objective specification,0.5728070175438597
Disease,nursing-home acquired infection,0.5552631578947369
Disease,reverse zoonotic disposition,0.5642857142857143
Disease,acute infection,0.5409090909090909
Disease,collective disposition,0.5879310344827586
InfectedNiece,infected population,0.73125
InfectedNiece,T cell receptor complex,0.5888888888888889
Infectious disease,infection incidence proportion profile,0.6642857142857143
Infectious disease,asymptomatic infectious agent carrier,0.7045454545454546
Infectious disease,infectious disposition,0.825
Infectious disease,fungicidal disposition,0.65
Infectious disease,collective pathogenic disposition,0.6460784313725491
Infectious disease,diseased population,0.6391891891891892
Infectious disease,primary infection role,0.7
Infectious disease,systematic infection,0.6605263157894737
Infectious disease,immunosuppressive disposition,0.6627659574468084
Infectious disease,incubation end process boundary,0.6540816326530612
Infectious disease,immunization against infectious agent,0.6863636363636364
Infectious disease,infectious disease course,0.8686046511627907
Infectious disease,disease transmission model,0.6318181818181818
Infectious disease,secondary infection role,0.6880952380952381
Infectious disease,collective resistance disposition,0.6460784313725491
Infectious disease,adhesion disposition,0.6605263157894737
Infectious disease,infectious agent colony,0.7670731707317073
Infectious disease,bactericidal disposition,0.6404761904761905
Infectious disease,static agent disposition,0.6404761904761905
Infectious disease,source of infection role,0.6880952380952381
Infectious disease,vaccination against infectious agent,0.6907407407407408
Infectious disease,community-acquired infection,0.6239130434782608
Infectious disease,toxin disposition,0.65
Infectious disease,secondary infection,0.6662162162162162
Infectious disease,symptomatic infectious structure carrier,0.7086206896551723
Infectious disease,source of infection site,0.7119047619047619
Infectious disease,primary infectious disposition,0.7625
Infectious disease,passive immunization against infectious agent,0.6563492063492063
Infectious disease,infection,0.7462962962962962
Infectious disease,infection incidence rate profile,0.71
Infectious disease,bacteriostatic disposition,0.6772727272727272
Infectious disease,latency end temporal region,0.6055555555555556
Infectious disease,communicability end process boundary,0.5981481481481481
Infectious disease,infectious disease lifetime prevalence,0.7714285714285714
Infectious disease,infectious disease mortality rate,0.8029411764705883
Infectious disease,infectious disorder,0.8554054054054054
Infectious disease,disposition,0.5879310344827586
Infectious disease,infectious disease control strategy,0.789622641509434
Infectious disease,infection incidence,0.7743243243243243
Infectious disease,herd immunity to infectious organism,0.6907407407407408
Infectious disease,passive immunity to infectious agent,0.6907407407407408
Infectious disease,infectious disease epidemic,0.85
Infectious disease,infectious agent host,0.7833333333333333
Infectious disease,appearance of disorder,0.65
Infectious disease,invasive disposition,0.6605263157894737
Infectious disease,sterilizing immunity to infectious agent,0.6741379310344828
Infectious disease,infection incidence profile,0.7166666666666667
Infectious disease,drug susceptibility of infectious agent,0.6780701754385965
Infectious disease,infectious agent generative stage,0.7441176470588234
Infectious disease,source of infection,0.6662162162162162
Infectious disease,long-term non-progressing infectious disease course,0.7108695652173913
Infectious disease,symptomatic infectious agent carrier,0.7092592592592593
Infectious disease,parasitostatic disposition,0.6545454545454545
Infectious disease,infectious disease sporadicity,0.825
Infectious disease,infectious agent,0.8323529411764706
Infectious disease,infectious disease pandemic,0.85
Infectious disease,humoral immunity to infectious agent,0.6907407407407408
Infectious disease,acute infectious disease course,0.8173469387755102
Infectious disease,infectious structure generative stage,0.740909090909091
Infectious disease,infection incidence proportion,0.7
Infectious disease,infection start temporal region,0.7153061224489795
Infectious disease,local infection,0.6924242424242425
Infectious disease,leukocyte-mediated immunity to infectious agent,0.65
Infectious disease,pathogenic disposition,0.625
Infectious disease,infectious agent population,0.7388888888888888
Infectious disease,primary infection,0.6785714285714286
Infectious disease,infectious disease endemicity,0.8329787234042553
Infectious disease,disease,0.73
Infectious disease,establishment of a clinically abnormal colony,0.5611111111111111
Infectious disease,transmissibility disposition,0.6239130434782608
Infectious disease,extracellular infection,0.6451219512195122
Infectious disease,infection start process boundary,0.69
Infectious disease,virulence factor disposition,0.6891304347826087
Infectious disease,incubation end temporal region,0.6791666666666666
Infectious disease,hospital-acquired infection,0.6277777777777778
Infectious disease,infectious structure,0.7921052631578948
Infectious disease,disorder,0.6038461538461539
Infectious disease,exotoxin disposition,0.6605263157894737
Infectious disease,infectious disease,0.95
Infectious disease,acquired immunity to infectious agent,0.6863636363636364
Infectious disease,opportunistic infectious disposition,0.7277777777777777
Infectious disease,fungistatic disposition,0.6451219512195122
Infectious disease,chronic infection,0.6785714285714286
Infectious disease,metastatic infection,0.6605263157894737
Infectious disease,infected population,0.6932432432432433
Infectious disease,latency end process boundary,0.6021739130434782
Infectious disease,process of establishing an infection,0.5981481481481481
Infectious disease,cytotoxin disposition,0.6551282051282051
Infectious disease,T cell receptor complex,0.5963414634146341
Infectious disease,intracellular infection,0.6451219512195122
Infectious disease,cidal agent disposition,0.6451219512195122
Infectious disease,infectious agent reservoir,0.7681818181818181
Infectious disease,subclinical infection,0.6551282051282051
Infectious disease,infectious pathogen transmissibility,0.7092592592592593
Infectious disease,infectious structure host role,0.7625
Infectious disease,zoonotic disposition,0.6605263157894737
Infectious disease,B cell receptor complex,0.5963414634146341
Infectious disease,asymptomatic infectious structure carrier,0.7042372881355932
Infectious disease,site of infection,0.6785714285714286
Infectious disease,endotoxin disposition,0.6551282051282051
Infectious disease,disease course,0.66875
Infectious disease,infectious disease prevalence,0.8329787234042553
Infectious disease,chronic infectious disease course,0.8029411764705883
Infectious disease,invasion disposition,0.6868421052631578
Infectious disease,infection prevalence,0.7657894736842106
Infectious disease,infection incidence rate,0.7595238095238095
Infectious disease,infection end temporal region,0.7265957446808511
Infectious disease,infectious structure aggregate,0.7625
Infectious disease,enterotoxin disposition,0.6695121951219513
Infectious disease,parasiticidal disposition,0.636046511627907
Infectious disease,simple infection,0.6852941176470588
Infectious disease,complex infection,0.6785714285714286
Infectious disease,infectious agent host role,0.7681818181818181
Infectious disease,active immunization against infectious agent,0.6596774193548387
Infectious disease,infectious human pathogen,0.7523255813953489
Infectious disease,infectious disease incidence proportion,0.7657894736842106
Infectious disease,infectious disease incidence rate,0.8029411764705883
Infectious disease,communicability end temporal region,0.6009433962264151
Infectious disease,neurotoxin disposition,0.675
Infectious disease,infectious disease incidence,0.8413043478260869
Infectious disease,innate immunity to infectious agent,0.6952830188679244
Infectious disease,infectious structure host,0.7755813953488372
Infectious disease,disease surveillance objective specification,0.6112903225806451
Infectious disease,infectious disease control objective specification,0.7147058823529412
Infectious disease,nursing-home acquired infection,0.6132653061224489
Infectious disease,reverse zoonotic disposition,0.6239130434782608
Infectious disease,susceptibility to infectious agent,0.7
Infectious disease,acute infection,0.6924242424242425
Infectious disease,collective disposition,0.675
InfectedViaHealthcareWork,healthcare facility,0.6772727272727272
InfectedViaHealthcareWork,establishment of a clinically abnormal colony,0.6071428571428572
InfectedViaHealthcareWork,infected population,0.7
InfectedViaHealthcareWork,T cell receptor complex,0.5958333333333333
Group,infection incidence rate profile,0.504054054054054
Group,infectious disease mortality rate,0.5026315789473684
Group,action specification,0.53
Group,T cell receptor complex,0.5571428571428572
Group,B cell receptor complex,0.5571428571428572
Group,infectious structure aggregate,0.5071428571428571
Group,infectious disease incidence rate,0.5026315789473684
Group,acellular structure aggregate,0.5088235294117647
Group,object aggregate,0.5452380952380953
COVID-19 dedicated facility,hospital facility,0.7227272727272727
COVID-19 dedicated facility,cell,0.5467741935483871
COVID-19 dedicated facility,incubation end process boundary,0.6224137931034482
COVID-19 dedicated facility,healthcare facility,0.7326086956521739
COVID-19 dedicated facility,source of infection role,0.6068627450980393
COVID-19 dedicated facility,source of infection site,0.6264705882352941
COVID-19 dedicated facility,infection incidence rate profile,0.6703389830508475
COVID-19 dedicated facility,latency end temporal region,0.6166666666666667
COVID-19 dedicated facility,communicability end process boundary,0.6246031746031746
COVID-19 dedicated facility,infectious disease mortality rate,0.6666666666666667
COVID-19 dedicated facility,source of infection,0.6021739130434782
COVID-19 dedicated facility,cell space,0.5851351351351352
COVID-19 dedicated facility,material entity,0.6404761904761905
COVID-19 dedicated facility,establishment of a clinically abnormal colony,0.5888888888888889
COVID-19 dedicated facility,incubation end temporal region,0.6254385964912281
COVID-19 dedicated facility,latency end process boundary,0.6136363636363636
COVID-19 dedicated facility,T cell receptor complex,0.61
COVID-19 dedicated facility,B cell receptor complex,0.61
COVID-19 dedicated facility,material processing,0.5804347826086956
COVID-19 dedicated facility,processed material,0.6277777777777778
COVID-19 dedicated facility,infection incidence rate,0.6460784313725491
COVID-19 dedicated facility,infection end temporal region,0.6285714285714286
COVID-19 dedicated facility,active immunization against infectious agent,0.6049295774647887
COVID-19 dedicated facility,facility,0.6785714285714286
COVID-19 dedicated facility,infectious disease incidence rate,0.6333333333333333
COVID-19 dedicated facility,communicability end temporal region,0.6435483870967742
COVID-19 dedicated facility,quality,0.5970588235294118
Gathering,infectious disease course,0.5382352941176471
Gathering,function,0.6264705882352941
Gathering,herd immunity to infectious organism,0.5833333333333334
Gathering,long-term non-progressing infectious disease course,0.5666666666666667
Gathering,acute infectious disease course,0.575
Gathering,action specification,0.6224137931034482
Gathering,establishment of a clinically abnormal colony,0.5425925925925926
Gathering,T cell receptor complex,0.54375
Gathering,B cell receptor complex,0.5125
Gathering,disease course,0.5804347826086956
Gathering,chronic infectious disease course,0.5452380952380953
Gathering,infectious structure aggregate,0.5525641025641026
Gathering,acellular structure aggregate,0.581578947368421
Gathering,object aggregate,0.61
Person,organism substance,0.575
Person,entity,0.6166666666666667
Person,organism,0.5928571428571429
Person,immunosuppressed organism,0.6112903225806451
Person,colonization of human,0.524074074074074
Person,pathologically immunosuppressed organism,0.558695652173913
Person,herd immunity to infectious organism,0.569047619047619
Person,resistant entity,0.5863636363636363
Person,drug-based immunosuppressed organism,0.569047619047619
Person,realizable entity,0.5369565217391304
Person,designative information content entity,0.5409090909090909
Person,material entity,0.5928571428571429
Person,immaterial entity,0.5804347826086956
Person,extended organism,0.5804347826086956
Person,division of geopolitical entity,0.5310810810810811
Person,establishment of a clinically abnormal colony,0.5284313725490196
Person,directive information content entity,0.5452380952380953
Person,susceptible organism,0.6038461538461539
Person,anatomical entity,0.5369565217391304
Person,immunodeficient organism,0.55
Person,T cell receptor complex,0.553448275862069
Person,molecular entity,0.5863636363636363
Person,organism population,0.61
Person,B cell receptor complex,0.553448275862069
Person,geopolitical entity,0.57
Person,descriptive information content entity,0.5636363636363636
Person,geographical entity,0.57
Person,information content entity,0.54375
Person,infectious human pathogen,0.5790322580645162
Person,immunocompetent organism,0.5833333333333334
UnionTerritory,T cell receptor complex,0.6121621621621621
SecurityGuard,establishment of a clinically abnormal colony,0.5706896551724138
SecurityGuard,T cell receptor complex,0.5611111111111111
Untested for COVID-19,infection incidence rate profile,0.619811320754717
Untested for COVID-19,infectious disease mortality rate,0.6166666666666667
Untested for COVID-19,establishment of a clinically abnormal colony,0.6166666666666667
Untested for COVID-19,T cell receptor complex,0.6318181818181818
Untested for COVID-19,B cell receptor complex,0.609090909090909
Untested for COVID-19,infection incidence rate,0.6277777777777778
Untested for COVID-19,infectious disease incidence rate,0.6166666666666667
town,pathogen death temporal region,0.5382352941176471
town,zero-dimensional temporal region,0.5333333333333333
town,incubation end process boundary,0.5357142857142857
town,communicability start temporal region,0.523170731707317
town,infectious disease course,0.5189655172413793
town,one-dimensional spatial region,0.5382352941176471
town,zero-dimensional spatial region,0.5357142857142857
town,spatiotemporal region,0.57
town,infection incidence rate profile,0.5333333333333333
town,latency end temporal region,0.5467741935483871
town,communicability end process boundary,0.525
town,infectious disease mortality rate,0.504054054054054
town,temporal region,0.6078947368421053
town,two-dimensional spatial region,0.5382352941176471
town,long-term non-progressing infectious disease course,0.5045454545454545
town,acute infectious disease course,0.5071428571428571
town,spatial region,0.6166666666666667
town,infection start temporal region,0.5357142857142857
town,one-dimensional temporal region,0.5357142857142857
town,local infection,0.6078947368421053
town,division of geopolitical entity,0.5071428571428571
town,place closure control strategy,0.5088235294117647
town,establishment of a clinically abnormal colony,0.5112244897959184
town,incubation end temporal region,0.5382352941176471
town,geographical region,0.5369565217391304
town,latency end process boundary,0.54375
town,T cell receptor complex,0.524074074074074
town,B cell receptor complex,0.524074074074074
town,disease course,0.5055555555555555
town,chronic infectious disease course,0.504054054054054
town,geographical entity,0.5369565217391304
town,infection incidence rate,0.5571428571428572
town,infection end temporal region,0.5409090909090909
town,three-dimensional spatial region,0.5333333333333333
town,infectious disease incidence rate,0.5310810810810811
town,communicability end temporal region,0.5269230769230769
town,pathogen birth temporal region,0.5382352941176471
town,geospatial region,0.5928571428571429
Moderate COVID-19,case isolation control strategy,0.575
Moderate COVID-19,quarantine control strategy,0.609090909090909
Moderate COVID-19,incubation end process boundary,0.5958333333333333
Moderate COVID-19,invasion factor,0.575
Moderate COVID-19,infection incidence rate profile,0.6540816326530612
Moderate COVID-19,latency end temporal region,0.5863636363636363
Moderate COVID-19,communicability end process boundary,0.6009433962264151
Moderate COVID-19,infectious disease mortality rate,0.61
Moderate COVID-19,infectious disease control strategy,0.6038461538461539
Moderate COVID-19,virulence factor,0.6015151515151516
Moderate COVID-19,vector control strategy,0.575
Moderate COVID-19,adhesion factor,0.60625
Moderate COVID-19,intermediate host role,0.6294871794871795
Moderate COVID-19,place closure control strategy,0.5776595744680851
Moderate COVID-19,establishment of a clinically abnormal colony,0.5629032258064516
Moderate COVID-19,virulence factor disposition,0.5833333333333334
Moderate COVID-19,incubation end temporal region,0.598936170212766
Moderate COVID-19,latency end process boundary,0.6055555555555556
Moderate COVID-19,object,0.5804347826086956
Moderate COVID-19,T cell receptor complex,0.6
Moderate COVID-19,intermediate host,0.6558823529411765
Moderate COVID-19,B cell receptor complex,0.6
Moderate COVID-19,infection incidence rate,0.6207317073170732
Moderate COVID-19,infection end temporal region,0.6021739130434782
Moderate COVID-19,infectious disease incidence rate,0.63
Moderate COVID-19,communicability end temporal region,0.5846153846153846
Moderate COVID-19,infectious disease control objective specification,0.5992537313432835
Moderate COVID-19,object aggregate,0.6318181818181818
SecondaryContact,contact tracing,0.7080645161290323
SecondaryContact,secondary infection role,0.75
SecondaryContact,secondary infection,0.7928571428571428
SecondaryContact,establishment of a clinically abnormal colony,0.5975409836065574
SecondaryContact,contact pathogen transmission process,0.6386792452830189
SecondaryContact,T cell receptor complex,0.6038461538461539
HealthCareProfessional,healthcare facility,0.7670731707317073
HealthCareProfessional,establishment of a clinically abnormal colony,0.6141791044776119
HealthCareProfessional,T cell receptor complex,0.6277777777777778
Viral disease,infection incidence proportion profile,0.5480392156862746
Viral disease,infectious disposition,0.6214285714285714
Viral disease,fungicidal disposition,0.6785714285714286
Viral disease,collective pathogenic disposition,0.6021739130434782
Viral disease,primary infection role,0.6214285714285714
Viral disease,systematic infection,0.5712121212121213
Viral disease,immunosuppressive disposition,0.6166666666666667
Viral disease,incubation end process boundary,0.5863636363636363
Viral disease,infectious disease course,0.6868421052631578
Viral disease,disease transmission model,0.6294871794871795
Viral disease,secondary infection role,0.5851351351351352
Viral disease,collective resistance disposition,0.6239130434782608
Viral disease,adhesion disposition,0.6318181818181818
Viral disease,bactericidal disposition,0.6662162162162162
Viral disease,static agent disposition,0.6391891891891892
Viral disease,source of infection role,0.5851351351351352
Viral disease,community-acquired infection,0.5719512195121951
Viral disease,toxin disposition,0.65
Viral disease,secondary infection,0.575
Viral disease,source of infection site,0.6121621621621621
Viral disease,primary infectious disposition,0.6127906976744186
Viral disease,infection,0.5409090909090909
Viral disease,infection incidence rate profile,0.5833333333333334
Viral disease,bacteriostatic disposition,0.6294871794871795
Viral disease,latency end temporal region,0.6
Viral disease,communicability end process boundary,0.5928571428571429
Viral disease,infectious disease lifetime prevalence,0.6264705882352941
Viral disease,infectious disease mortality rate,0.6456521739130434
Viral disease,infectious disorder,0.6375
Viral disease,disposition,0.6166666666666667
Viral disease,infectious disease control strategy,0.6375
Viral disease,infection incidence,0.60625
Viral disease,infectious disease epidemic,0.675
Viral disease,appearance of disorder,0.65
Viral disease,invasive disposition,0.6621212121212122
Viral disease,infection incidence profile,0.575
Viral disease,source of infection,0.575
Viral disease,long-term non-progressing infectious disease course,0.590625
Viral disease,parasitostatic disposition,0.6294871794871795
Viral disease,infectious disease sporadicity,0.6593023255813953
Viral disease,infectious disease pandemic,0.675
Viral disease,acute infectious disease course,0.6545454545454545
Viral disease,infection incidence proportion,0.5662790697674418
Viral disease,infection start temporal region,0.5863636363636363
Viral disease,local infection,0.6285714285714286
Viral disease,pathogenic disposition,0.6214285714285714
Viral disease,primary infection,0.6166666666666667
Viral disease,infectious disease endemicity,0.6642857142857143
Viral disease,disease,0.8
Viral disease,establishment of a clinically abnormal colony,0.553448275862069
Viral disease,transmissibility disposition,0.6451219512195122
Viral disease,extracellular infection,0.6166666666666667
Viral disease,infection start process boundary,0.5611111111111111
Viral disease,virulence factor disposition,0.6695121951219513
Viral disease,incubation end temporal region,0.6127906976744186
Viral disease,hospital-acquired infection,0.6
Viral disease,disorder,0.6404761904761905
Viral disease,exotoxin disposition,0.6318181818181818
Viral disease,infectious disease,0.7403225806451613
Viral disease,opportunistic infectious disposition,0.5724489795918367
Viral disease,fungistatic disposition,0.6444444444444444
Viral disease,chronic infection,0.5833333333333334
Viral disease,metastatic infection,0.5712121212121213
Viral disease,latency end process boundary,0.5719512195121951
Viral disease,process of establishing an infection,0.5928571428571429
Viral disease,cytotoxin disposition,0.6264705882352941
Viral disease,T cell receptor complex,0.5611111111111111
Viral disease,intracellular infection,0.6444444444444444
Viral disease,cidal agent disposition,0.6722222222222223
Viral disease,subclinical infection,0.6264705882352941
Viral disease,zoonotic disposition,0.6318181818181818
Viral disease,B cell receptor complex,0.5611111111111111
Viral disease,site of infection,0.5833333333333334
Viral disease,endotoxin disposition,0.6264705882352941
Viral disease,disease course,0.7092592592592593
Viral disease,infectious disease prevalence,0.6642857142857143
Viral disease,chronic infectious disease course,0.6456521739130434
Viral disease,invasion disposition,0.6621212121212122
Viral disease,infection prevalence,0.6318181818181818
Viral disease,infection incidence rate,0.6121621621621621
Viral disease,infection end temporal region,0.5928571428571429
Viral disease,enterotoxin disposition,0.6166666666666667
Viral disease,parasiticidal disposition,0.6605263157894737
Viral disease,simple infection,0.6224137931034482
Viral disease,complex infection,0.5833333333333334
Viral disease,negative regulation of viral process,0.6132653061224489
Viral disease,infectious disease incidence proportion,0.6230769230769231
Viral disease,infectious disease incidence rate,0.6456521739130434
Viral disease,communicability end temporal region,0.6166666666666667
Viral disease,neurotoxin disposition,0.6214285714285714
Viral disease,infectious disease incidence,0.6695121951219513
Viral disease,disease surveillance objective specification,0.5903508771929825
Viral disease,infectious disease control objective specification,0.5928571428571429
Viral disease,nursing-home acquired infection,0.5636363636363636
Viral disease,reverse zoonotic disposition,0.6207317073170732
Viral disease,acute infection,0.5928571428571429
Viral disease,collective disposition,0.6214285714285714
Exposure to COVID-19,incubation end process boundary,0.5872549019607843
Exposure to COVID-19,latency end temporal region,0.598936170212766
Exposure to COVID-19,communicability end process boundary,0.5928571428571429
Exposure to COVID-19,susceptibility,0.5970588235294118
Exposure to COVID-19,drug susceptibility of infectious agent,0.5855932203389831
Exposure to COVID-19,drug susceptibility,0.5782051282051281
Exposure to COVID-19,place closure control strategy,0.65
Exposure to COVID-19,establishment of a clinically abnormal colony,0.573076923076923
Exposure to COVID-19,incubation end temporal region,0.59
Exposure to COVID-19,latency end process boundary,0.5958333333333333
Exposure to COVID-19,T cell receptor complex,0.636046511627907
Exposure to COVID-19,B cell receptor complex,0.636046511627907
Exposure to COVID-19,infection end temporal region,0.6132653061224489
Exposure to COVID-19,communicability end temporal region,0.5954545454545455
Exposure to COVID-19,susceptibility to infectious agent,0.6166666666666667
State,case isolation control strategy,0.5888888888888889
State,incubation end process boundary,0.5333333333333333
State,site,0.7833333333333333
State,source of infection site,0.5879310344827586
State,infection incidence rate profile,0.5581081081081081
State,latency end temporal region,0.54375
State,communicability end process boundary,0.523170731707317
State,infectious disease mortality rate,0.581578947368421
State,establishment of a clinically abnormal colony,0.53
State,incubation end temporal region,0.5357142857142857
State,pathogen portal of entry site,0.5676470588235294
State,latency end process boundary,0.5409090909090909
State,T cell receptor complex,0.5571428571428572
State,pathogen portal of exit site,0.5712121212121213
State,B cell receptor complex,0.5214285714285714
State,site of infection,0.5863636363636363
State,infection incidence rate,0.5879310344827586
State,infection end temporal region,0.5382352941176471
State,infectious disease incidence rate,0.5552631578947369
State,communicability end temporal region,0.525
Comorbidity,T cell receptor complex,0.5382352941176471
Comorbidity,B cell receptor complex,0.5382352941176471
Organization,organism substance,0.7166666666666667
Organization,infectious disposition,0.6264705882352941
Organization,fungicidal disposition,0.6558823529411765
Organization,collective pathogenic disposition,0.6277777777777778
Organization,case isolation control strategy,0.6127906976744186
Organization,quarantine control strategy,0.6294871794871795
Organization,immunosuppressive disposition,0.6207317073170732
Organization,incubation end process boundary,0.5895348837209302
Organization,surveillance process,0.575
Organization,vector surveillance,0.6112903225806451
Organization,collective resistance disposition,0.65
Organization,adhesion disposition,0.66875
Organization,bactericidal disposition,0.6444444444444444
Organization,organism,0.75
Organization,static agent disposition,0.6444444444444444
Organization,architectual structure,0.5676470588235294
Organization,negative regulation of replication,0.6673913043478261
Organization,toxin disposition,0.6913793103448276
Organization,immunosuppressed organism,0.6121621621621621
Organization,symptomatic infectious structure carrier,0.5653846153846154
Organization,negative regulation of immune response,0.61
Organization,primary infectious disposition,0.6404761904761905
Organization,infection incidence rate profile,0.5863636363636363
Organization,bacteriostatic disposition,0.6342105263157894
Organization,latency end temporal region,0.6038461538461539
Organization,communicability end process boundary,0.5958333333333333
Organization,negative regulation of developmental process,0.5928571428571429
Organization,infectious disease mortality rate,0.5833333333333334
Organization,disposition,0.7108695652173913
Organization,infectious disease control strategy,0.5563829787234043
Organization,negative regulation of establishment of localization,0.621875
Organization,pathologically immunosuppressed organism,0.5846153846153846
Organization,herd immunity to infectious organism,0.5958333333333333
Organization,invasive disposition,0.6375
Organization,drug-based immunosuppressed organism,0.575
Organization,acellular structure,0.5467741935483871
Organization,parasitostatic disposition,0.6605263157894737
Organization,infectious structure generative stage,0.5928571428571429
Organization,plan specification,0.7166666666666667
Organization,extended organism,0.656896551724138
Organization,pathogenic disposition,0.6852941176470588
Organization,vector control strategy,0.5928571428571429
Organization,place closure control strategy,0.569047619047619
Organization,establishment of a clinically abnormal colony,0.5728070175438597
Organization,transmissibility disposition,0.65
Organization,virulence factor disposition,0.625
Organization,incubation end temporal region,0.5928571428571429
Organization,infectious structure,0.575
Organization,exotoxin disposition,0.66875
Organization,opportunistic infectious disposition,0.6166666666666667
Organization,fungistatic disposition,0.65
Organization,susceptible organism,0.6375
Organization,negative regulation of production,0.6277777777777778
Organization,immunodeficient organism,0.6166666666666667
Organization,latency end process boundary,0.55
Organization,cytotoxin disposition,0.6621212121212122
Organization,T cell receptor complex,0.5357142857142857
Organization,cidal agent disposition,0.65
Organization,establishment of localization,0.6695121951219513
Organization,negative regulation of biological process,0.6009433962264151
Organization,organism population,0.8048387096774193
Organization,infectious structure host role,0.5452380952380953
Organization,zoonotic disposition,0.66875
Organization,B cell receptor complex,0.5357142857142857
Organization,pathogen surveillance,0.6318181818181818
Organization,asymptomatic infectious structure carrier,0.5632075471698114
Organization,endotoxin disposition,0.6621212121212122
Organization,establishment of localization in host,0.6336734693877552
Organization,invasion disposition,0.66875
Organization,biological regulation,0.6924242424242425
Organization,infection incidence rate,0.5888888888888889
Organization,infection end temporal region,0.5963414634146341
Organization,infectious structure aggregate,0.569047619047619
Organization,enterotoxin disposition,0.65
Organization,parasiticidal disposition,0.6662162162162162
Organization,negative regulation of viral process,0.6166666666666667
Organization,immunocompetent organism,0.6166666666666667
Organization,infectious disease incidence rate,0.5833333333333334
Organization,communicability end temporal region,0.6202127659574468
Organization,acellular structure aggregate,0.5475609756097561
Organization,neurotoxin disposition,0.6558823529411765
Organization,infectious structure host,0.5581081081081081
Organization,disease surveillance objective specification,0.6107142857142857
Organization,infectious disease control objective specification,0.5951612903225807
Organization,reverse zoonotic disposition,0.625
Organization,negative regulation of life-sustaining process,0.5879310344827586
Organization,collective disposition,0.6264705882352941
Country wise statistics,pathogen death temporal region,0.6009433962264151
Country wise statistics,infection incidence proportion profile,0.6139344262295081
Country wise statistics,diseased population,0.6166666666666667
Country wise statistics,zero-dimensional temporal region,0.5772727272727273
Country wise statistics,incubation end process boundary,0.5981481481481481
Country wise statistics,communicability start temporal region,0.6666666666666667
Country wise statistics,one-dimensional spatial region,0.6386792452830189
Country wise statistics,susceptible population,0.6277777777777778
Country wise statistics,zero-dimensional spatial region,0.6166666666666667
Country wise statistics,normal resident microbiota population,0.6166666666666667
Country wise statistics,source of infection role,0.6202127659574468
Country wise statistics,spatiotemporal region,0.5863636363636363
Country wise statistics,source of infection site,0.6627659574468084
Country wise statistics,infection incidence rate profile,0.6318181818181818
Country wise statistics,latency end temporal region,0.61
Country wise statistics,communicability end process boundary,0.6364406779661017
Country wise statistics,infectious disease mortality rate,0.6642857142857143
Country wise statistics,temporal region,0.581578947368421
Country wise statistics,two-dimensional spatial region,0.6386792452830189
Country wise statistics,source of infection,0.6404761904761905
Country wise statistics,designative information content entity,0.6139344262295081
Country wise statistics,cell space,0.6318181818181818
Country wise statistics,material entity,0.6342105263157894
Country wise statistics,acute infectious disease course,0.6722222222222223
Country wise statistics,infection incidence proportion,0.619811320754717
Country wise statistics,spatial region,0.5851351351351352
Country wise statistics,infection start temporal region,0.6351851851851852
Country wise statistics,one-dimensional temporal region,0.5981481481481481
Country wise statistics,country,0.6833333333333332
Country wise statistics,plan specification,0.6207317073170732
Country wise statistics,infectious agent population,0.63
Country wise statistics,establishment of a clinically abnormal colony,0.5823529411764706
Country wise statistics,incubation end temporal region,0.619811320754717
Country wise statistics,geographical region,0.569047619047619
Country wise statistics,directive information content entity,0.6194915254237288
Country wise statistics,process that results in death,0.6230769230769231
Country wise statistics,infected population,0.6166666666666667
Country wise statistics,latency end process boundary,0.5872549019607843
Country wise statistics,T cell receptor complex,0.5804347826086956
Country wise statistics,anatomical space,0.6294871794871795
Country wise statistics,organism population,0.6404761904761905
Country wise statistics,B cell receptor complex,0.558695652173913
Country wise statistics,material processing,0.6166666666666667
Country wise statistics,processed material,0.6207317073170732
Country wise statistics,descriptive information content entity,0.6139344262295081
Country wise statistics,infection incidence rate,0.6414893617021277
Country wise statistics,infection end temporal region,0.6230769230769231
Country wise statistics,immune population,0.625
Country wise statistics,information content entity,0.6336734693877552
Country wise statistics,simple infection,0.6038461538461539
Country wise statistics,active immunization against infectious agent,0.6440298507462687
Country wise statistics,infectious disease incidence proportion,0.6274193548387097
Country wise statistics,three-dimensional spatial region,0.6318181818181818
Country wise statistics,infectious disease incidence rate,0.6464285714285714
Country wise statistics,communicability end temporal region,0.656896551724138
Country wise statistics,pathogen birth temporal region,0.6009433962264151
Country wise statistics,geospatial region,0.6
Country wise statistics,acute infection,0.6605263157894737
InfectedViaPoliceWork,establishment of a clinically abnormal colony,0.6015151515151516
InfectedViaPoliceWork,infected population,0.775
InfectedViaPoliceWork,T cell receptor complex,0.609090909090909
Patient,case isolation control strategy,0.581578947368421
Patient,incubation end process boundary,0.581578947368421
Patient,specifically dependent continuant,0.6
Patient,passive immunization against infectious agent,0.5846153846153846
Patient,infection incidence rate profile,0.5782051282051281
Patient,latency end temporal region,0.5970588235294118
Patient,communicability end process boundary,0.5430232558139535
Patient,infectious disease mortality rate,0.55
Patient,passive immunity to infectious agent,0.6127906976744186
Patient,establishment of a clinically abnormal colony,0.5461538461538461
Patient,incubation end temporal region,0.6121621621621621
Patient,latency end process boundary,0.5642857142857143
Patient,T cell receptor complex,0.55
Patient,ribonucleic acid,0.5369565217391304
Patient,generically dependent continuant,0.5782051282051281
Patient,B cell receptor complex,0.55
Patient,infection incidence rate,0.6112903225806451
Patient,infection end temporal region,0.5888888888888889
Patient,nucleic acid,0.5552631578947369
Patient,infectious disease incidence rate,0.575
Patient,communicability end temporal region,0.569047619047619
Patient,deoxyribonucleic acid,0.5214285714285714
COVID-19 Diagnosis,incubation end process boundary,0.5928571428571429
COVID-19 Diagnosis,genetic resistance to pathogen,0.575
COVID-19 Diagnosis,latency end temporal region,0.5833333333333334
COVID-19 Diagnosis,communicability end process boundary,0.5981481481481481
COVID-19 Diagnosis,acute infectious disease course,0.6132653061224489
COVID-19 Diagnosis,geospatial location,0.5851351351351352
COVID-19 Diagnosis,plan specification,0.5888888888888889
COVID-19 Diagnosis,division of geopolitical entity,0.5928571428571429
COVID-19 Diagnosis,place closure control strategy,0.575
COVID-19 Diagnosis,establishment of a clinically abnormal colony,0.5452380952380953
COVID-19 Diagnosis,incubation end temporal region,0.5958333333333333
COVID-19 Diagnosis,latency end process boundary,0.5804347826086956
COVID-19 Diagnosis,T cell receptor complex,0.5475609756097561
COVID-19 Diagnosis,B cell receptor complex,0.5475609756097561
COVID-19 Diagnosis,infection end temporal region,0.598936170212766
COVID-19 Diagnosis,communicability end temporal region,0.6009433962264151
COVID-19 Diagnosis,quality,0.53
COVID-19 Diagnosis,acute infection,0.6015151515151516
InfectedNephew,infected population,0.7227272727272727
InfectedNephew,T cell receptor complex,0.5851351351351352
